Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of IAH0968 with gemcitabine and cisplatin in HER2-positive advanced solid tumors and biliary tract cancer
CTR20223087Phase 2Active
- Sponsor
- SUNHO BioPharmaceutical
- Start
- Jul 2023
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of IAH0968, gemcitabine, cisplatin in Nonhematologic neoplasms, biliary cancer, sponsored by SUNHO BioPharmaceutical. Started Jul 2023; status: active.
02
Drugs
IAH0968gemcitabinecisplatin
03
Conditions
Nonhematologic neoplasmsbiliary cancer
Beyond the preview
Go deeper on CTR20223087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223087.